Incorporation of chlorpromazine into bilayer liposomes for protection against microsomal metabolism and liver absorptionSCHWENDENER, R. A.European journal of drug metabolism and pharmacokinetics. 1988, Vol 13, Num 2, pp 135-141, issn 0378-7966Article

The preparation of large volumes of homogeneous, sterile liposomes containing various lipophilic cytostatic drugs by the use of a capillary dialyzerSCHWENDENER, R. A.Cancer drug delivery. 1986, Vol 3, Num 2, pp 123-129, issn 0732-9482Article

Synthesis and structure-activity studies in vivo of liposomal phospholipid-N⁴-palmitoyl- and N⁴-hexadecyl-1-β-D-arabinofuranosylcytosine conjugatesSCHOTT, H; SCHWENDENER, R. A.Anti-cancer drug design. 1996, Vol 11, Num 6, pp 451-462, issn 0266-9536Article

Lipophilic 1-β-D-arabinofuranosyl cytosine derivatives in liposomal formulations for oral and parenteral antileukemic therapy in the murine L1210 leukemia modelSCHWENDENER, R. A; SCHOTT, H.Journal of cancer research and clinical oncology. 1996, Vol 122, Num 12, pp 723-726, issn 0171-5216Article

Synthese von 4-Alkylcytosinnucleosiden und deren cytostatische Wirkung im L1210 Leukämiemodell der Maus = Synthesis of 4-alkylcytosine nucleosides and evaluation of cytostatic activity in the L1210 murine leukemiaSCHOTT, H; HÄUSSLER, M. P; SCHWENDENER, R. A et al.Liebigs Annalen der Chemie. 1994, Num 5, pp 465-470, issn 0170-2041Article

Cellular pharmacology of a liposomal preparation of N⁴-hexadecyl-1-β-D-arabinofuranosylcytosine, a lipophilic derivative of 1-β-D-arabinofuranosylcytosineHORBER, D. H; SCHOTT, H; SCHWENDENER, R. A et al.British journal of cancer. 1995, Vol 71, Num 5, pp 957-962, issn 0007-0920Article

Determination of mitoxantrone in mouse whole blood and different tissues by high-performance liquid chromatographyRENTSCH, K. M; SCHWENDENER, R. A; HÄNSELER, E et al.Journal of chromatography. B, Biomedical applications. 1996, Vol 679, Num 1-2, pp 185-192Article

Cellular pharmacology of N⁴-hexadecyl-1-β-D-arabinofuranosylcytosine in the human leukemic cell lines K-562 and U-937HORBER, D. H; SCHOTT, H; SCHWENDENER, R. A et al.Cancer chemotherapy and pharmacology. 1995, Vol 36, Num 6, pp 483-492, issn 0344-5704Article

Chromatography of functionalized liposomes and their componentsSCHOTT, H; LEITNER, B; SCHWENDENER, R. A et al.Journal of chromatography. 1988, Vol 441, Num 1, pp 115-124, issn 0021-9673Conference Paper

The effects of charge and size on the interaction of unilamellar liposomes with macrophagesSCHWENDENER, R. A; LAGOCKI, P. A; RAHMAN, Y. E et al.Biochimica et biophysica acta. 1984, Vol 772, Num 1, pp 93-101, issn 0006-3002Article

Low density lipoprotein and liposome mediated uptake and cytotoxic effect of N⁴-octadecyl-1-β-D-arabinofuranosylcytosine in Daudi lymphoma cellsKOLLER-LUCAE, S. K. M; SCHOTT, H; SCHWENDENER, R. A et al.British journal of cancer. 1999, Vol 80, Num 10, pp 1542-1549, issn 0007-0920Article

Syntheses if lipophilic amino and carboxyl components for the functionalization of liposomesSCHOTT, H; HESS, W; HENGARTNER, H et al.Biochimica et biophysica acta. 1988, Vol 943, Num 1, pp 53-62, issn 0006-3002Article

Cell cycle-dependent cytotoxicity and induction of apoptosis by liposomal N⁴-hexadecyl-1-β-D-arabinofuranosylcytosineHORBER, D. H; VON BALLMOOS, P; SCHOTT, H et al.British journal of cancer. 1995, Vol 72, Num 5, pp 1067-1073, issn 0007-0920Article

New lipophilic alkyl/acyl dinucleoside phosphates as derivatives of 3'-azido-3'-deoxythymidine : inhibition of HIV-1 replication in vitro and antiviral activity against Rauscher leukemia virus infected mice with delayed treatment regimensSCHWENDENER, R. A; GOWLAND, P; HORBER, D. H et al.Antiviral research. 1994, Vol 24, Num 1, pp 79-93, issn 0166-3542Article

Comparative studies of the preparation of immunoliposomes with the use of two bifunctional coupling agents and investigation of in vitro immunoliposome-target cell binding by cytofluorometry and electron microscopySCHWENDENER, R. A; TRUÊB, T; SCHOTT, H et al.Biochimica et biophysica acta. 1990, Vol 1026, Num 1, pp 69-79, issn 0006-3002, 11 p.Article

(Na⁺+K⁺)-ATPase in artificial lipid vesicles: influence of lipid structure on pumping rateMARCUS, M. M; APELL, H.-J; ROUDNA, M et al.Biochimica et biophysica acta. 1986, Vol 854, Num 2, pp 270-278, issn 0006-3002Article

5'-O-Palmitoyl- and 3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine ― novel lipophilic analogues of 5'-fluoro-2'-deoxyuridine: synthesis, incorporation into liposomes and preliminary biological resultsSCHWENDENER, R. A; SUPERSAXO, A; RUBAS, W et al.Biochemical and biophysical research communications (Print). 1985, Vol 126, Num 2, pp 660-666, issn 0006-291XArticle

Toxicity of liposomal 3'-5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine in miceVAN BORSSUM WAALKES, M; GORIS, H; DONTJE, B. H. J et al.Anti-cancer drug design. 1998, Vol 13, Num 4, pp 291-305, issn 0266-9536Article

Evaluation of incorporation characteristics of mitoxantrone into unilamellar liposomes and analysis of their pharmacokinetic properties, acute toxicity, and antitumor efficacySCHWENDENER, R. A; FIEBIG, H. H; BERGER, M. R et al.Cancer chemotherapy and pharmacology. 1991, Vol 27, Num 6, pp 429-439, issn 0344-5704, 11 p.Article

The antitumour effect of lipophilic derivatives of 5-fluoro-2'-deoxyuridine incorporated into liposomesSUPERSAXO, A; RUBAS, W; HARTMANN, H. R et al.Journal of microencapsulation. 1988, Vol 5, Num 1, pp 1-11, issn 0265-2048Article

Clodronate-liposome-mediated depletion of tumour-associated macrophages : a new and highly effective antiangiogenic therapy approachZEISBERGER, S. M; ODERMATT, B; MARTY, C et al.British journal of cancer. 2006, Vol 95, Num 3, pp 272-281, issn 0007-0920, 10 p.Article

Cell-cycle arrest and p53-independent induction of apoptosis in vitro by the new anticancer drugs 5-FdUrd-P-FdCydOct and dCydPam-P-FdUrd in DU-145 human prostate cancer cellsCATTANEO-PANGRAZZI, R. M. C; SCHOTT, H; WUNDERLI-ALLENSPACH, H et al.Journal of cancer research and clinical oncology. 2000, Vol 126, Num 5, pp 247-256, issn 0171-5216Article

Cytotoxicity, cell-cycle perturbations and apoptosis in human tumor cells by lipophilic N⁴-alkyl-1-β-D-arabinofuranosylcytosine derivatives and the new heteronucleoside phosphate dimer arabinocytidylyl-(5' → 5')-N⁴-octadecyl-1-β-D-arabinofuranosylcytosineHORBER, D. H; CATTANEO-PANGRAZZI, R. M. C; VON BALLMOOS, P et al.Journal of cancer research and clinical oncology. 2000, Vol 126, Num 6, pp 311-319, issn 0171-5216Article

In vivo antigen loading and activation of dendritic cells via a liposomal peptide vaccine mediates protective antiviral and anti-tumour immunityLUDEWIG, B; BARCHIESI, F; PERICIN, M et al.Vaccine. 2000, Vol 19, Num 1, pp 23-32, issn 0264-410XArticle

In vitro anti-human immunodeficiency virus and anti-hepatitis B virus activities and pharmacokinetic properties of heterodinucleoside phosphates containing AZT or ddCPEGHINI, P. A; ZAHNER, R; KUSTER, H et al.Antiviral chemistry & chemotherapy. 1998, Vol 9, Num 2, pp 117-126, issn 0956-3202Article